Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1274 | 753 | 0.0744 | 0.0748 | 0.5911 | 0.5989 |
A-375 | Vemurafenib | Defactinib | 3.160 | 1.000 | uM | 72 | hr | 3 | 1822 | 269 | 0.0744 | 0.0857 | 0.1476 | 0.1490 |
A-375 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 3 | 1534 | 520 | 0.0744 | 0.0866 | 0.3390 | 0.3091 |
A-375 | Vemurafenib | JNK-IN-8 | 1.000 | 3.160 | uM | 72 | hr | 3 | 1458 | 273 | 0.0745 | 0.0897 | 0.1872 | 0.1612 |
A-375 | Vemurafenib | (+)-JQ1 | 0.316 | 1.000 | uM | 72 | hr | 3 | 1536 | 471 | 0.0753 | 0.0952 | 0.3066 | 0.3084 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1374 | 845 | 0.0756 | 0.0722 | 0.6150 | 0.5817 |
COLO 858 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1163 | 835 | 0.0758 | 0.0871 | 0.7180 | 0.7176 |
A-375 | Vemurafenib | I-BET151 | 3.160 | 1.000 | uM | 72 | hr | 3 | 1653 | 605 | 0.0758 | 0.0884 | 0.3660 | 0.3475 |
COLO 858 | Vemurafenib | I-BET | 3.160 | 1.000 | uM | 72 | hr | 2 | 1336 | 1087 | 0.0761 | 0.0728 | 0.8136 | 0.8214 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1347 | 812 | 0.0764 | 0.0748 | 0.6028 | 0.5989 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 1 | 972 | 720 | 0.0765 | 0.0787 | 0.7407 | 0.7868 |
A-375 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1899 | 295 | 0.0769 | 0.0825 | 0.1553 | 0.1694 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 2 | 1849 | 762 | 0.0769 | 0.0702 | 0.4121 | 0.4350 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 0.000 | uM | 72 | hr | 3 | 1747 | 1411 | 0.0771 | 0.0685 | 0.8077 | 0.8137 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 3 | 1002 | 665 | 0.0773 | 0.0829 | 0.6637 | 0.6809 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1227 | 686 | 0.0773 | 0.0722 | 0.5591 | 0.5817 |
A-375 | Vemurafenib | (+)-JQ1 | 1.000 | 1.000 | uM | 72 | hr | 1 | 1979 | 884 | 0.0774 | 0.0702 | 0.4467 | 0.4350 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1638 | 157 | 0.0775 | 0.0717 | 0.0958 | 0.0989 |
COLO 858 | Vemurafenib | (+)-JQ1 | 0.316 | 1.000 | uM | 72 | hr | 3 | 923 | 667 | 0.0777 | 0.0899 | 0.7226 | 0.7359 |
A-375 | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1554 | 62 | 0.0781 | 0.0757 | 0.0399 | 0.0403 |
A-375 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1622 | 180 | 0.0784 | 0.0695 | 0.1110 | 0.1086 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 3 | 1480 | 1221 | 0.0786 | 0.0787 | 0.8250 | 0.7868 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 1744 | 239 | 0.0788 | 0.0842 | 0.1370 | 0.1524 |
COLO 858 | Vemurafenib | Belinostat | 1.000 | 1.000 | uM | 72 | hr | 1 | 1214 | 870 | 0.0789 | 0.0829 | 0.7166 | 0.6809 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 2 | 1263 | 917 | 0.0794 | 0.0767 | 0.7260 | 0.7291 |